Duke Collier

Duke Collier currently serves as CEO of Arsenal Medical and is a Senior Advisor with Polaris Ventures. Prior to his role at Polaris, Mr. Collier was Executive Vice President at Genzyme where he managed and built several of Genzyme’s newer businesses, including its oncology and cardiovascular business units. During his tenure at Genzyme, Mr. Collier was responsible for building the biosurgery business and oversees the company’s efforts in multiple sclerosis and other immune disorders. He has also led some of Genzyme’s significant acquisitions and the formation of MG Biotherapeutics, Genzyme’s joint venture with Medtronic Inc., which is focused on cardiac cell therapy.

Mr. Collier has more than 30 years of experience in healthcare. From 1991-1995, he was president of Vitas Healthcare Corp., the largest provider of hospice services in the United States. Between 1981 and 1991, Mr. Collier was a partner at Hogan & Hartson law firm in Washington, D.C. He served as deputy administrator for the Health Care Financing Administration (HCFA) in Baltimore, MD, during the Carter Administration. From 1977 to 1979, Mr. Collier was deputy administrator of the New York State offices of Health Systems Management. He was an associate at Covington and Burlington law firm in Washington, D.C., from 1974 to 1977. Mr. Collier began his legal career in Washington as a clerk for the U.S. Court of Appeals.